NCT00569192: A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children |
|
|
| Completed | 3 | 360 | US | 0.135mg MAP0010, 0.25mg MAP0010, Placebo | Allergan, MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan | Asthma | 09/08 | 01/09 | | |
NCT00697697: A Study of 2 Doses of MAP0010 in Asthmatic Children |
|
|
| Terminated | 3 | 192 | US | 0.135mg MAP0010, 0.25mg MAP0010 | Allergan, MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan | Asthma | 08/09 | 12/09 | | |
